Göppner, D. (2014) “High Incidence of Naevi-associated BRAF Wild-type Melanoma and Dysplastic Naevi under Treatment with the Class I BRAF Inhibitor Vemurafenib”, Acta Dermato-Venereologica, 94(5), pp. 517–520. doi: 10.2340/00015555-1813.